DISTREPTAZA

This brand name is authorized in Malta, Poland

Active ingredients

The drug DISTREPTAZA contains a combination of these active pharmaceutical ingredients (APIs):

1 Streptokinase UNII 8X1OXL3SNU - STREPTOKINASE

Biofactor streptokinase is a highly purified streptokinase derived from β haemolytic streptococci of Lancefield group C. The activation of the endogenous fibrinolytic system is initiated by the formation of a streptokinase-plasminogen complex. This complex possesses activator properties and converts plasminogen into the proteolytic and fibrinolytic active plasmin. Read about Streptokinase

2 Streptodornase UNII DV8J2R3544 - STREPTODORNASE

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AD01	Streptokinase	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AD Enzymes
Discover more medicines within B01AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): AA1379/00201
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100019657